应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02627 中慧生物-B
交易中 12-05 14:38:49
41.040
+0.320
+0.79%
最高
41.300
最低
40.020
成交量
16.94万
今开
40.040
昨收
40.720
日振幅
3.14%
总市值
161.47亿
流通市值
121.63亿
总股本
3.93亿
成交额
692.80万
换手率
0.06%
流通股本
2.96亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
中慧生物-B(02627)提名李建军为独立非执行董事候选人
智通财经 · 12-04 22:19
中慧生物-B(02627)提名李建军为独立非执行董事候选人
突破!慧尔康欣首次出口澳门——四价流感病毒亚单位疫苗助力澳门地区健康防护
智通财经 · 12-04 11:48
突破!慧尔康欣首次出口澳门——四价流感病毒亚单位疫苗助力澳门地区健康防护
决胜港股升浪・致敬卓越力量,“第十届智通财经资本市场年会暨上市公司颁奖盛典”25项大奖揭晓!
智通财经 · 12-03 19:21
决胜港股升浪・致敬卓越力量,“第十届智通财经资本市场年会暨上市公司颁奖盛典”25项大奖揭晓!
中慧生物-B11月27日获主力加仓121.5万元
市场透视 · 11-27
中慧生物-B11月27日获主力加仓121.5万元
中慧生物-B11月25日主力净流入260.4万元 散户资金抛售
市场透视 · 11-25
中慧生物-B11月25日主力净流入260.4万元 散户资金抛售
决胜港股升浪·牛启东方2026——第十届智通财经资本市场年会邀您共赴资本盛宴
智通财经 · 11-18
决胜港股升浪·牛启东方2026——第十届智通财经资本市场年会邀您共赴资本盛宴
中慧生物-B盘中异动 早盘股价大跌5.56%
市场透视 · 11-17
中慧生物-B盘中异动 早盘股价大跌5.56%
中慧生物-B(02627):四价流感病毒亚单位疫苗(佐剂)及三价流感病毒亚单位疫苗(佐剂)的I期临床试验启动
智通财经 · 11-13
中慧生物-B(02627):四价流感病毒亚单位疫苗(佐剂)及三价流感病毒亚单位疫苗(佐剂)的I期临床试验启动
中慧生物-B11月07日获主力加仓234.2万元
市场透视 · 11-07
中慧生物-B11月07日获主力加仓234.2万元
引领流感疫苗进阶之路,中慧生物-B(02627)有望填补母婴疫苗市场空白
智通财经 · 11-06
引领流感疫苗进阶之路,中慧生物-B(02627)有望填补母婴疫苗市场空白
多地完成扩龄上市首诊接种,中慧生物-B(02627)商业化进程全面提速
智通财经 · 11-03
多地完成扩龄上市首诊接种,中慧生物-B(02627)商业化进程全面提速
中慧生物-B10月28日主力净流出32.8万元 散户资金买入
市场透视 · 10-28
中慧生物-B10月28日主力净流出32.8万元 散户资金买入
中慧生物-B10月20日获主力加仓525.4万元
市场透视 · 10-20
中慧生物-B10月20日获主力加仓525.4万元
中慧生物-B(02627)申请H股全流通
智通财经 · 10-15
中慧生物-B(02627)申请H股全流通
中慧生物-B10月13日主力净流出35.6万元 散户资金买入
市场透视 · 10-13
中慧生物-B10月13日主力净流出35.6万元 散户资金买入
中慧元通/怡道生物重组带状疱疹疫苗(CHO细胞)启动III期临床适应症为预防带状疱疹
动脉网 · 10-11
中慧元通/怡道生物重组带状疱疹疫苗(CHO细胞)启动III期临床适应症为预防带状疱疹
中慧生物-B10月02日获主力加仓33万元
市场透视 · 10-02
中慧生物-B10月02日获主力加仓33万元
中慧生物-B09月30日获主力加仓50.8万元
市场透视 · 09-30
中慧生物-B09月30日获主力加仓50.8万元
中慧生物-B:2025中期报告
香港交易所 · 09-29
中慧生物-B:2025中期报告
港股医药股反弹 中慧生物涨超5%
南方财经网 · 09-17
港股医药股反弹 中慧生物涨超5%
加载更多
公司概况
公司名称:
中慧生物-B
所属市场:
SEHK
上市日期:
--
主营业务:
江苏中慧元通生物科技股份有限公司是一家主要从事疫苗的研发、制造及商业化中国公司。该公司的产品管线包括两种核心产品,即四价流感病毒亚单位疫苗及在研冻干人用狂犬病疫苗,以及其他11种在研疫苗。该公司主要在中国市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02627","market":"HK","secType":"STK","nameCN":"中慧生物-B","latestPrice":41.04,"timestamp":1764916634800,"preClose":40.72,"halted":0,"volume":169400,"delay":0,"floatShares":296361845,"shares":393442600,"eps":-0.791704804145941,"marketStatus":"交易中","change":0.32,"latestTime":"12-05 14:38:49","open":40.04,"high":41.3,"low":40.02,"amount":6927956,"amplitude":0.031434,"askPrice":41.2,"askSize":800,"bidPrice":41.04,"bidSize":1600,"shortable":0,"etf":0,"ttmEps":-0.6867761422977823,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1764922200000},"marketStatusCode":2,"adr":0,"listingDate":1754841600000,"exchange":"SEHK","adjPreClose":40.72,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":0.957743,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02627","defaultTab":"news","newsList":[{"id":"2588804788","title":"中慧生物-B(02627)提名李建军为独立非执行董事候选人","url":"https://stock-news.laohu8.com/highlight/detail?id=2588804788","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588804788?lang=zh_cn&edition=full","pubTime":"2025-12-04 22:19","pubTimestamp":1764857965,"startTime":"0","endTime":"0","summary":"智通财经APP讯,中慧生物-B(02627)公布,李晓青女士因欲投入更多时间于个人的其他事务,已向董事会辞任公司独立非执行董事、董事会审计委员会主席、董事会薪酬与考核委员会成员及董事会提名委员会成员职务。此外,李建军先生已获提名担任董事会第二届独立非执行董事候选人,惟须待公司临时股东会审议及批准后方始作实。李建军先生已获委任为董事会审计委员会主席及董事会薪酬与考核委员会成员,而于建林先生不再担任董事会提名委员会成员,李润香女士则已获委任为董事会提名委员会成员及陈乘贝先生获委任为董事会提名委员会成员,全部均自李建军先生于临时股东会获选为公司独立非执行董事之日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377908.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02627","BK1161"],"gpt_icon":0},{"id":"2588077396","title":"突破!慧尔康欣首次出口澳门——四价流感病毒亚单位疫苗助力澳门地区健康防护","url":"https://stock-news.laohu8.com/highlight/detail?id=2588077396","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588077396?lang=zh_cn&edition=full","pubTime":"2025-12-04 11:48","pubTimestamp":1764820082,"startTime":"0","endTime":"0","summary":"国际化战略迈出关键一步近日,中慧生物-B自主研发的四价流感病毒亚单位疫苗——慧尔康欣顺利运抵澳门特别行政区并完成通关,成功实现首次出口,正式进入澳门市场。当前正值流感季,澳门特别行政区持续加强呼吸道传染病防控。本次疫苗的及时引入,将为澳门居民提供优质、可靠的免疫选择,助力当地筑牢公共卫生防线。首针仪式顺利举行,携手共建健康澳门12月4日,该疫苗在澳门银葵医院成功举行首针接种仪式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377608.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159646","BK1161","02627"],"gpt_icon":0},{"id":"2588048711","title":"决胜港股升浪・致敬卓越力量,“第十届智通财经资本市场年会暨上市公司颁奖盛典”25项大奖揭晓!","url":"https://stock-news.laohu8.com/highlight/detail?id=2588048711","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588048711?lang=zh_cn&edition=full","pubTime":"2025-12-03 19:21","pubTimestamp":1764760876,"startTime":"0","endTime":"0","summary":"2025年12月3日,由国内领先的港美股资讯平台智通财经与中资海外私募基金一站式服务平台新智基金网联合主办、财经公关综合服务提供商冬日暖阳 Donova 独家承办的 “第十届智通财经资本市场年会暨上市公司颁奖盛典” 在深圳盛大启幕。荣耀加冕:231 家企业及管理者斩获 25 项年度大奖当晚的颁奖典礼星光熠熠,各项大奖实至名归。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377197.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02105","00136","00300","00867","00020","00267","00460","00826","00798","00003","00777","00451","02279","02380","00305","00363","00666","00992","00017","00999","00875","00861","01093","02525","00135","00656","00382","01070","09678","02121","09699","00384","00302","00855","00699","02498","02627","00884","02419","01833","09878","00512","00960","02256","06160","02556","02142","02511"],"gpt_icon":1},{"id":"2586277200","title":"中慧生物-B11月27日获主力加仓121.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586277200","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586277200?lang=zh_cn&edition=full","pubTime":"2025-11-27 16:15","pubTimestamp":1764231350,"startTime":"0","endTime":"0","summary":"11月27日, 中慧生物-B股价涨1.68%,报收41.18元,成交金额610.4万元,换手率0.05%,振幅3.80%,量比0.93。中慧生物-B今日主力资金净流入121.5万元,连续3日净流入,上一交易日主力净流入81.6万元。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为50.00%,平均涨幅为2.30%。该股近5个交易日上涨2.44%,主力资金累计净流入463.6万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入664.0万元,其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127162056a4bda518&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127162056a4bda518&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02627","BK1161"],"gpt_icon":0},{"id":"2586406268","title":"中慧生物-B11月25日主力净流入260.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2586406268","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586406268?lang=zh_cn&edition=full","pubTime":"2025-11-25 16:15","pubTimestamp":1764058532,"startTime":"0","endTime":"0","summary":"11月25日, 中慧生物-B股价涨2.79%,报收41.20元,成交金额700.1万元,换手率0.06%,振幅2.50%,量比1.04。中慧生物-B今日主力资金净流入260.4万元,上一交易日主力净流出36.1万元。该股近5个交易日上涨2.80%,主力资金累计净流入260.6万元;近20日主力资金累计净流入392.0万元,其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125161754977e2dbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125161754977e2dbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02627","BK1161"],"gpt_icon":0},{"id":"2584023605","title":"决胜港股升浪·牛启东方2026——第十届智通财经资本市场年会邀您共赴资本盛宴","url":"https://stock-news.laohu8.com/highlight/detail?id=2584023605","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584023605?lang=zh_cn&edition=full","pubTime":"2025-11-18 08:53","pubTimestamp":1763427196,"startTime":"0","endTime":"0","summary":"由港美股第一资讯平台智通财经与中资海外私募基金一站式服务平台新智基金网联合主办,“冬日暖阳” 独家承办,S&P Global Market Intelligence、CITIZEN支持的“第十届智通财经资本市场年会”将于2025年12月3-5日联动深圳与香港两地举行。本届年会以\"决胜港股升浪·牛启东方2026\"为主题,设置六大核心议程,汇聚全球资本力量,共探宽松周期尾声的领涨赛道与中国资产长期增长潜力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1370226.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00699","06996","02171","01228","00861","09911","06660","02167","00826","00290","00604","02511","00003","02268","02453","02177","02431","00855","02096","02142","00196","00302","02627","00382","02509","09996","01164","06682","06609","02488","09959","00305","06608","09878","02587","00363","00552","02561","01167","02256","02279","02420","01333","02105","03658","02670","02157","09678","00867","01318"],"gpt_icon":0},{"id":"2584616752","title":"中慧生物-B盘中异动 早盘股价大跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584616752","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584616752?lang=zh_cn&edition=full","pubTime":"2025-11-17 10:22","pubTimestamp":1763346150,"startTime":"0","endTime":"0","summary":"2025年11月17日早盘10时22分,中慧生物-B股票出现波动,股价快速下挫5.56%。中慧生物-B股票所在的生物技术行业中,整体跌幅为2.99%。其相关个股中,中生北控生物科技、旺山旺水-B、来凯医药-B涨幅较大,振幅较大的相关个股有派格生物医药-B、中生北控生物科技、旺山旺水-B,振幅分别为27.98%、21.36%、18.26%。中慧生物-B公司简介:江苏中慧元通生物科技股份有限公司是一家主要从事疫苗的研发、制造及商业化中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117102230976dd9b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117102230976dd9b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2583955292","title":"中慧生物-B(02627):四价流感病毒亚单位疫苗(佐剂)及三价流感病毒亚单位疫苗(佐剂)的I期临床试验启动","url":"https://stock-news.laohu8.com/highlight/detail?id=2583955292","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583955292?lang=zh_cn&edition=full","pubTime":"2025-11-13 16:36","pubTimestamp":1763023019,"startTime":"0","endTime":"0","summary":"集团已于2024年7月就在研四价流感病毒亚单位疫苗(佐剂)及于2024年10月就在研三价流感病毒亚单位疫苗(佐剂)取得中华人民共和国国家药品监督管理局的新药临床试验申请批准。集团的四价流感病毒亚单位疫苗(佐剂)及三价流感病毒亚单位疫苗(佐剂)专为65岁及以上人群设计,由于添加了类MF59佐剂,免疫反应增强,提高了抗体滴度,为该年龄群体提供更佳保护。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1368784.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","159646","02627"],"gpt_icon":0},{"id":"2581509855","title":"中慧生物-B11月07日获主力加仓234.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581509855","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581509855?lang=zh_cn&edition=full","pubTime":"2025-11-07 16:15","pubTimestamp":1762503359,"startTime":"0","endTime":"0","summary":"11月07日, 中慧生物-B股价涨1.25%,报收40.50元,成交金额623.9万元,换手率0.05%,振幅3.25%,量比0.89。中慧生物-B今日主力资金净流入234.2万元,上一交易日主力净流入37.1万元。该股近5个交易日上涨0.50%,主力资金累计净流入271.3万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入1527.8万元,其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110716223194f535fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110716223194f535fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2581803615","title":"引领流感疫苗进阶之路,中慧生物-B(02627)有望填补母婴疫苗市场空白","url":"https://stock-news.laohu8.com/highlight/detail?id=2581803615","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581803615?lang=zh_cn&edition=full","pubTime":"2025-11-06 11:59","pubTimestamp":1762401543,"startTime":"0","endTime":"0","summary":"近期,中慧生物-B接连迎来重要进展。因此,若中慧生物的该项研究取得积极成果,慧尔康欣则有望成为中国首个专用于孕妇的流感疫苗。此举不仅将填补中国在孕妇流感疫苗本土临床数据方面的空白,推动孕妇群体的流感防控进程,更将助力中慧生物率先切入孕妇流感疫苗这一潜力市场,进一步巩固其在高端疫苗领域的差异化竞争优势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1365908.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02627","159646"],"gpt_icon":0},{"id":"2580571432","title":"多地完成扩龄上市首诊接种,中慧生物-B(02627)商业化进程全面提速","url":"https://stock-news.laohu8.com/highlight/detail?id=2580571432","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580571432?lang=zh_cn&edition=full","pubTime":"2025-11-03 12:52","pubTimestamp":1762145576,"startTime":"0","endTime":"0","summary":"从市场格局来看,当前国内流感疫苗市场仍以第二代普通裂解流感疫苗为主流,而中慧生物-B开发的“亚单位”流感疫苗属于第三代技术路线,在安全性、免疫效果和整体品质方面具备明显优势。随着秋冬季流感高峰临近,目前中慧生物这款亚单位流感疫苗已在全国完成26个省份的扩龄备案准入,并在沈阳、济南、上海、武汉、昆明、福州等多地完成扩龄上市首诊接种。其快速的商业化落地能力,将成为中慧生物未来业绩与价值兑现的核心催化剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1364337.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2578953553","title":"中慧生物-B10月28日主力净流出32.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2578953553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578953553?lang=zh_cn&edition=full","pubTime":"2025-10-28 16:15","pubTimestamp":1761639338,"startTime":"0","endTime":"0","summary":"10月28日, 中慧生物-B股价跌4.53%,报收40.90元,成交金额579.3万元,换手率0.05%,振幅5.84%,量比0.97。中慧生物-B今日主力资金净流出32.8万元,上一交易日主力净流入35.2万元。该股近5个交易日下跌10.70%,主力资金累计净流入660.9万元;近20日主力资金累计净流入1401.9万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251028161937a47942b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251028161937a47942b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02627","BK1161"],"gpt_icon":0},{"id":"2577811169","title":"中慧生物-B10月20日获主力加仓525.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577811169","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577811169?lang=zh_cn&edition=full","pubTime":"2025-10-20 16:15","pubTimestamp":1760948155,"startTime":"0","endTime":"0","summary":"10月20日, 中慧生物-B股价涨3.26%,报收45.00元,成交金额1662.8万元,换手率0.13%,振幅7.16%,量比2.85。中慧生物-B今日主力资金净流入525.4万元,上一交易日主力净流入34.1万元。该股近5个交易日上涨0.27%,主力资金累计净流入559.4万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入614.9万元,其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102016213294d379c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102016213294d379c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2575977786","title":"中慧生物-B(02627)申请H股全流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2575977786","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575977786?lang=zh_cn&edition=full","pubTime":"2025-10-15 19:17","pubTimestamp":1760527078,"startTime":"0","endTime":"0","summary":"智通财经APP讯,中慧生物-B(02627)发布公告,于2025年10月15日,公司已就将公司8166.2万股未上市股份转换为H股以及该等股份于联交所上市向中国证监会提交申请。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1355491.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02627","BK1161"],"gpt_icon":0},{"id":"2575823742","title":"中慧生物-B10月13日主力净流出35.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2575823742","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575823742?lang=zh_cn&edition=full","pubTime":"2025-10-13 16:16","pubTimestamp":1760343365,"startTime":"0","endTime":"0","summary":"10月13日, 中慧生物-B股价跌4.47%,报收44.88元,成交金额440.4万元,换手率0.03%,振幅4.17%,量比0.57。中慧生物-B今日主力资金净流出35.6万元,上一交易日主力净流入27.5万元。该股近5个交易日下跌6.77%,主力资金累计净流入28.7万元;近20日主力资金累计净流入197.1万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251013162316a45d4a03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251013162316a45d4a03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2574465106","title":"中慧元通/怡道生物重组带状疱疹疫苗(CHO细胞)启动III期临床适应症为预防带状疱疹","url":"https://stock-news.laohu8.com/highlight/detail?id=2574465106","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574465106?lang=zh_cn&edition=full","pubTime":"2025-10-11 18:30","pubTimestamp":1760178600,"startTime":"0","endTime":"0","summary":"江苏中慧元通生物科技有限公司与上海怡道生物科技有限公司联合研发的重组带状疱疹疫苗(CHO细胞)已启动Ⅲ期临床试验,登记号CTR20254023,首次公示日期为2025年10月11日。该疫苗为注射剂,用于40岁及以上成人预防带状疱疹,接种方式为上臂三角肌肌内注射,每次0.5mL,共接种2次,分别在第0月和第2月进行。试验主要目的是评价全程接种后36个月内预防带状疱疹的保护持久性,次要目的为评价36个月免疫持久性。主要终点指标为全程接种后36个月内带状疱疹确诊病例的人年发病率,次要终点指标包括抗-gE抗体阳性率、GMC。目前试验状态为进行中,目标入组7500人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101118443294c30be4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101118443294c30be4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["91190","02627","BK1161"],"gpt_icon":0},{"id":"2572427975","title":"中慧生物-B10月02日获主力加仓33万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572427975","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572427975?lang=zh_cn&edition=full","pubTime":"2025-10-02 16:15","pubTimestamp":1759392938,"startTime":"0","endTime":"0","summary":"10月02日, 中慧生物-B股价涨1.22%,报收49.90元,成交金额1285.1万元,换手率0.09%,振幅5.07%,量比1.21。中慧生物-B今日主力资金净流入33万元,连续3日净流入,上一交易日主力净流入50.8万元。该股近5个交易日上涨3.96%,主力资金累计净流入128.3万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入208.0万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100216183894b848aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100216183894b848aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02627","BK1161"],"gpt_icon":0},{"id":"2572302669","title":"中慧生物-B09月30日获主力加仓50.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572302669","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572302669?lang=zh_cn&edition=full","pubTime":"2025-09-30 16:15","pubTimestamp":1759220140,"startTime":"0","endTime":"0","summary":"09月30日, 中慧生物-B股价涨5.88%,报收49.30元,成交金额1073.5万元,换手率0.07%,振幅6.57%,量比1.06。中慧生物-B今日主力资金净流入50.8万元,上一交易日主力净流入44.5万元。该股近5个交易日上涨1.78%,主力资金累计净流入95.3万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入138.2万元,其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509301619419719f664&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509301619419719f664&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2571408319","title":"中慧生物-B:2025中期报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2571408319","media":"香港交易所","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571408319?lang=zh_cn&edition=full","pubTime":"2025-09-29 16:57","pubTimestamp":1759136244,"startTime":"0","endTime":"0","summary":"中慧生物2025年上半年收入达7112.3万元,较去年同期的697.8万元大幅增长919%,主要受益于四价流感病毒亚单位疫苗销售增长。期内毛利6078.1万元,毛利率达85.5%。公司核心产品四价流感病毒亚单位疫苗已完成6-35月龄人群III期临床试验,并于2025年9月获国家药监局批准用于该年龄段人群。三价流感病毒亚单位疫苗的新药申请已于2024年9月获国家药监局受理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092919005697b0c9db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092919005697b0c9db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2568045358","title":"港股医药股反弹 中慧生物涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568045358","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568045358?lang=zh_cn&edition=full","pubTime":"2025-09-17 09:32","pubTimestamp":1758072736,"startTime":"0","endTime":"0","summary":"南方财经9月17日电,港股医药股反弹,截至发稿,中慧生物-B(02627.HK)涨5.47%、同源康医药-B(02410.HK)涨5.13%、荣昌生物(09995.HK)涨2.70%、药明巨诺-B(02126.HK)涨2.54%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202509173515712278.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","09995","LU1969619763.USD","BK1583","LU2328871848.SGD","02410","02126","02627","BK1574"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abbbio.com","stockEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":0.0124},{"period":"3month","weight":-0.1727},{"period":"6month","weight":2.1566},{"period":"ytd","weight":2.1566}],"compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":-0.0006},{"period":"3month","weight":0.0204},{"period":"6month","weight":0.0901},{"period":"1year","weight":0.3137},{"period":"ytd","weight":0.2929}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"江苏中慧元通生物科技股份有限公司是一家主要从事疫苗的研发、制造及商业化中国公司。该公司的产品管线包括两种核心产品,即四价流感病毒亚单位疫苗及在研冻干人用狂犬病疫苗,以及其他11种在研疫苗。该公司主要在中国市场开展业务。","exchange":"SEHK","name":"中慧生物-B","nameEN":"AB&B BIO-TECH-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中慧生物-B(02627)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中慧生物-B(02627)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中慧生物-B,02627,中慧生物-B股票,中慧生物-B股票老虎,中慧生物-B股票老虎国际,中慧生物-B行情,中慧生物-B股票行情,中慧生物-B股价,中慧生物-B股市,中慧生物-B股票价格,中慧生物-B股票交易,中慧生物-B股票购买,中慧生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中慧生物-B(02627)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中慧生物-B(02627)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}